Poland· PL-100107373
Tears Naturale II
A künstliche tränenflüssigkeit und sonstige indifferente präparate product containing dextranum + hypromellosum, registered in Poland by Alcon Polska Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Künstliche tränenflüssigkeit und sonstige indifferente präparate is registered in 11 of 19 countries.
Countries holding a registration under ATC S01XA20 (künstliche tränenflüssigkeit und sonstige indifferente präparate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Künstliche tränenflüssigkeit und sonstige indifferente präparate · ATC S01XA20
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Dextranum + Hypromellosum
- Manufacturer
- Alcon Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- S01XA20
- ATC class
- Künstliche Tränenflüssigkeit und sonstige indifferente Präparate
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990930913
- gtin05909990930920
- gtin05909990930937
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01XA20
Künstliche tränenflüssigkeit und sonstige indifferente präparate, as other registers publish it.
- BelgiumAlcon Eye Gel 3 mg/gAlcon
- CanadaALCON TEARS 0.5%ALCON CANADA INC
- CanadaALCON TEARS 1%ALCON CANADA INC
- CanadaAMO ENDOSOL SOLUTIONAMO CANADA COMPANY
- DenmarkArtelacBausch & Lomb Ireland Limited
- FinlandArtelacBausch + Lomb Ireland Limited
- FinlandArtelacBausch + Lomb Ireland Limited
- NorwayArtelacBAUSCH + LOMB IRELAND LIMITED
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d5841d5f-5955-40b7-86f3-700344cca38e GET /v1/drugs/d5841d5f-5955-40b7-86f3-700344cca38e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "(1 mg + 3 mg)/ml",
"packaging": "05909990930913 ¦ OTC ¦ Skasowane ¦ 18735\n1 op. 5 ml\n05909990930920 ¦ OTC ¦ Skasowane ¦ 18737\n1 op. 10 ml\n05909990930937 ¦ OTC ¦ 18738\n1 op. 15 ml",
"substance": "Hypromellosum 3 mg + Dextranum 1 mg",
"common_name": "Dextranum + Hypromellosum",
"pl_product_id": "100107373",
"pozwolenie_nr": "09309",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about künstliche tränenflüssigkeit und sonstige indifferente präparate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.